Christopher A. Bravery
Impact in
- Virology top 5%
- HIV Research and Treatment
- Immunology top 10%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
- Virology 3
- Immunology 11
- T-cell and B-cell Immunology 7
- Immune Cell Function and Interaction 5
- Co-authors
- Magdi H. YacoubPuspa BattenMarlene L. RoseLouisa TaoElaine MitchellThomas LehnerYufei WangScott R. Burger
- Journals
- Transplantation (6 papers)Cytotherapy (4 papers)Journal of The Royal Society Interface (2 papers)Oncogene (2 papers)Molecular Therapy — Methods & Clinical Development (1 paper)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Christopher A. Bravery
29 papers receiving 770 citations
Peers
Comparison fields: 5 of 79
- Virology 165
- Immunology 277
- Genetics 76
- Transplantation 14
- Surgery 229
Countries citing papers authored by Christopher A. Bravery
This map shows the geographic impact of Christopher A. Bravery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Bravery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Bravery more than expected).
Fields of papers citing papers by Christopher A. Bravery
This network shows the impact of papers produced by Christopher A. Bravery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Bravery. The network helps show where Christopher A. Bravery may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher A. Bravery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2020 | 32 | |
| 3 | 2014 | 42 | |
| 4 | 2014 | 40 | |
| 5 | 2014 | 7 | |
| 6 | 2010 | 7 | |
| 7 | 2006 | 28 | |
| 8 | 2005 | 17 | |
| 9 | 2005 | 5 | |
| 10 | 2004 | 1 | |
| 11 | 2002 | 1 | |
| 12 | 2001 | 19 | |
| 13 | 2000 | 24 | |
| 14 | 2000 | 10 | |
| 15 | 2000 | 41 | |
| 16 | 1999 | 34 | |
| 17 | 1999 | 86 | |
| 18 | 1998 | 56 | |
| 19 | 1998 | 29 | |
| 20 | Importance of donor-reactive cytotoxic antibodies following cardiac transplantation. | 1991 | 1 |
About Christopher A. Bravery
Christopher A. Bravery is a scholar working on Virology, Immunology, Physiology, Physiology and Molecular Biology, having authored 29 papers that have together received 797 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (7 papers), Pluripotent Stem Cells Research (6 papers), Xenotransplantation and immune response (6 papers), Biomedical Ethics and Regulation (5 papers), Immune Cell Function and Interaction (5 papers), Organ Donation and Transplantation (4 papers), Renal and related cancers (4 papers) and 3D Printing in Biomedical Research (4 papers). The work is most often cited by research in Virology (165 citations), Immunology (277 citations), Genetics (76 citations), Transplantation (14 citations) and Surgery (229 citations). Christopher A. Bravery has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Magdi H. Yacoub, Puspa Batten, Marlene L. Rose, Louisa Tao, Elaine Mitchell, Thomas Lehner, Yufei Wang, Scott R. Burger, Timothy Fong and Jon A. Rowley. Their work appears in journals such as Transplantation, Cytotherapy, Journal of The Royal Society Interface, Oncogene and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.